Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Work In Process (2024 - 2025)

Historic Work In Process for Legend Biotech (LEGN) over the last 2 years, with Q1 2025 value amounting to $4.9 million.

  • Legend Biotech's Work In Process changed N/A to $4.9 million in Q1 2025 from the same period last year, while for Mar 2025 it was $4.9 million, marking a year-over-year change of. This contributed to the annual value of $4.4 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q1 2025, Legend Biotech's Work In Process is $4.9 million.
  • Legend Biotech's 5-year Work In Process high stood at $4.9 million for Q1 2025, and its period low was $4.4 million during Q4 2024.